The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients
NCT ID: NCT05662137
Last Updated: 2023-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2023-01-15
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: In this study, it was aimed to examine the effect of emotion recognition and expression program on alexithymia and emotion expression in patients with schizophrenia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Evaluation of a Psychoeducation Program in Individuals Diagnosed With Schizophrenia
NCT03865186
The Mindfulness-Based Psycho-Educational Program Focused on Emotion Regulation Strategies
NCT06926049
Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia
NCT04681807
The Effect of Social Skills Intervention on Praxis and Social Functioning in Individuals With Schizophrenia
NCT05901922
Effect of Simulation on Emotional Expression and Perceived Family Burden of Caregivers
NCT06723977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
At the beginning of the study, data collection tools Personal Information Form, Expression of Emotions Scale, Toronto Alexithymia Scale, Positive and Negative Syndrome Scale will be applied to the control group.
No intervention will be made in the control group. Measurement tools will be applied for the posttest. Emotional Expression Scale, Toronto Alexithymia Scale and Positive and Negative Syndrome Scale will be reapplied 1 month after the last session.
No interventions assigned to this group
Experimental group
Emotion recognition and expression program is aimed to be carried out in 8-week sessions for schizophrenia patients included in the experimental group. Personal Information Form, Expression of Emotions Scale, Toronto Alexithymia Scale, Positive and Negative Syndrome Scale will be applied to the experiment. The principal investigator will lead the structured group sessions as the group leader.
The principal investigator will lead the structured group sessions as the group leader.
Each group is planned to be 60-90 minutes. Before sessions, participants are taken from their previous session's emotions so far. Homework is discussed by providing recall of the topic from the previous session, and then the current topic is moved on. At the end of each session, a general summary and evaluation is made. After the sessions in the research, measurement tools will be applied for the posttest. It will be reapplied 1 month after the last session.
Emotions Recognition and Expression
Emotion recognition and expression program consisting of 8 sessions will be used. In this program, patients will have the opportunity to describe their emotions, explain emotions that are difficult to express such as anger, sadness, shame, guilt, and discuss the consequences of suppressed emotions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emotions Recognition and Expression
Emotion recognition and expression program consisting of 8 sessions will be used. In this program, patients will have the opportunity to describe their emotions, explain emotions that are difficult to express such as anger, sadness, shame, guilt, and discuss the consequences of suppressed emotions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being able to read and communicate
* Being 18 years of age or older,
* Not having mental retardation,
* Not having insight, understanding, hearing problems,
* Being in remission,
* Volunteering to study
Exclusion Criteria
* Being under the age of 18,
* Having mental retardation,
* Having no insight,
* Not understanding and hearing,
* Not in remission
* Refusing to participate in the study
* Stop studying at any stage of the study
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sinop University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adeviye AYDIN, PhD
Role: PRINCIPAL_INVESTIGATOR
Sinop University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sinop Community Mental Health Center
Sinop, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sınopUadeviye-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.